Aurobindo Pharma has posted consolidated net loss of Rs. 285.40 million for the quarter ended December 31, 2011 as compared to net profit of Rs. 1,886.30 million for the quarter ended December 31, 2010.

Total Income has increased by 7.62% from Rs. 11,980.80 million for the quarter ended December 31, 2010 to Rs. 12,894.50 million for the quarter ended December 31, 2011.

The company has posted a standalone net profit of Rs. 129.30 million for the quarter ended December 31, 2011 as compared to Rs. 1,838.50 million for the quarter ended December 31, 2010, registering a sharp fall of 92.96%. Total Income has increased by 4% from Rs. 11,576.60 million for the quarter ended December 31, 2010 to Rs. 12,031.80 million for the quarter ended December 31, 2011.

Shares of the company declined Rs 1.2, or 1.08%, to settle at Rs 109.45. The total volume of shares traded was 274,773 at the BSE.